Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H11N |
| Molecular Weight | 121.1796 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(C)=C1N
InChI
InChIKey=UFFBMTHBGFGIHF-UHFFFAOYSA-N
InChI=1S/C8H11N/c1-6-4-3-5-7(2)8(6)9/h3-5H,9H2,1-2H3
| Molecular Formula | C8H11N |
| Molecular Weight | 121.1796 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| HPLC-DAD stability indicating determination of nitrofurazone and lidocaine hydrochloride in their combined topical dosage form. | 2010-09 |
|
| Investigating the mechanisms of aromatic amine-induced protein free radical formation by quantitative structure-activity relationships: implications for drug-induced agranulocytosis. | 2010-05-17 |
|
| Third-order nonlinear optical properties and structures of (E)-N-(4-nitrobenzylidene)-2,6-dimethylaniline and (E)-N-(4-nitrobenzylidene)-2,3-dimethylaniline. | 2010-05 |
|
| N-(2,6-Dimethyl-phen-yl)-4-methyl-benzene-sulfonamide. | 2010-04-24 |
|
| Chemical oxidation of 2,6-dimethylaniline by electrochemically generated Fenton's reagent. | 2010-04-15 |
|
| N-(2,6-Dimethyl-phen-yl)succinimide. | 2010-01-09 |
|
| Monocyclic aromatic amines as potential human carcinogens: old is new again. | 2010-01 |
|
| Kinetics and mechanism of 2,6-dimethyl-aniline degradation by hydroxyl radicals. | 2009-12-30 |
|
| N-(2,6-Dimethyl-phen-yl)-2-(2-thien-yl)acetamide. | 2009-11-25 |
|
| Chemical oxidation of 2,6-dimethylaniline in the fenton process. | 2009-11-15 |
|
| Iron-catalyzed dehydrogenative phosphonation of N,N-dimethylanilines. | 2009-10-28 |
|
| N-(2,6-Dimethyl-phen-yl)maleamic acid. | 2009-10-23 |
|
| Separation and analysis of dimethylaniline isomers by supercritical fluid chromatography--electrospray ionization tandem mass spectrometry. | 2009-10-09 |
|
| Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques. | 2009-09 |
|
| N-[3-(2,6-Dimethylanilino)-1-methylbut-2-enylidene]-2,6-dimethylanilinium chloride. | 2009-06-24 |
|
| Ethyl 2-[(2,6-dimethyl-phen-yl)hydrazono]-3-oxobutanoate. | 2009-06-10 |
|
| Mixed carbene-isocyanide Pd(II) complexes: synthesis, structures and reactivity towards nucleophiles. | 2009-03-28 |
|
| N-(2,6-Dimethyl-phen-yl)succinamic acid. | 2009-02-06 |
|
| Kinetics of 2,6-dimethylaniline degradation by electro-Fenton process. | 2009-01-30 |
|
| The importance of CH/pi hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase. | 2008-12-15 |
|
| 2,6-Dimethyl-anilinium chloride monohydrate. | 2008-11-29 |
|
| N-(2,6-Dimethyl-phen-yl)benzene-sulfonamide. | 2008-08-06 |
|
| Assessment of the medicines lidocaine, prilocaine, and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues. | 2008-08 |
|
| Quantitative mass spectrometric analysis of ropivacaine and bupivacaine in authentic, pharmaceutical and spiked human plasma without chromatographic separation. | 2008-05-28 |
|
| N-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-ylcarbon-yl)-N'-(2,6-dimethyl-phen-yl)thio-urea. | 2007-12-06 |
|
| Temperature investigations of E/Z isomers in ketimines based of p-dibenzoylobenzene with aniline and 2,6-dimethylaniline by infrared spectroscopy. | 2007-10 |
|
| Expedient syntheses of the N-heterocyclic carbene precursor imidazolium salts IPr.HCl, IMes.HCl and IXy.HCl. | 2007-08-28 |
|
| Liquid-phase microextraction-gas chromatography-mass spectrometry for the determination of bromate, iodate, bromide and iodide in high-chloride matrix. | 2007-05-04 |
|
| Similarities and differences between azomethines and ketimines: synthesis, materials characterization and structure of novel imines compounds. | 2007-04 |
|
| In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations. | 2007-01 |
|
| Pi-Pi complexation of bupivacaine and analogues with aromatic receptors: implications for overdose remediation. | 2007 |
|
| Amine mediated proton transfer reaction and C-Cl bond activation of solvent chloroform by a trinuclear copper(II) complex of a glucopyranosylamine derived ligand. | 2006-08-21 |
|
| DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. | 2006-08 |
|
| Production and characterization of laccase from Cyathus bulleri and its use in decolourization of recalcitrant textile dyes. | 2006-08 |
|
| Synthesis, structure, and characterization of molybdenum(VI) imido complexes with N-salicylidene-2-aminophenol. | 2006-07-10 |
|
| Changes in production of lignin degrading enzymes during interactions between mycelia of the tropical decomposer basidiomycetes Marasmiellus troyanus and Marasmius pallescens. | 2006-02 |
|
| Regioselective copper-catalyzed amination of chlorobenzoic acids: synthesis and solid-state structures of N-aryl anthranilic acid derivatives. | 2006-01-06 |
|
| A kinetically controlled trans bifunctionalized organoimido derivative of the Lindqvist-type hexamolybdate: synthesis, spectroscopic characterization, and crystal structure of (n-Bu4N)2{trans-[Mo6O17(NAr)2]} (Ar = 2,6-dimethylphenyl). | 2005-12-26 |
|
| Primary amido substituted diborane4 compounds and imidodiborate4 anions. | 2005-10-07 |
|
| Determination of local anaesthetics and their impurities in pharmaceutical preparations using HPLC method with amperometric detection. | 2005-04-29 |
|
| Synthesis, structure and pharmacology of acyl-2,6-xylidines. | 2004-10-16 |
|
| Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. | 2004-10-06 |
|
| Metabolic activation of 2,6-xylidine in the nasal olfactory mucosa and the mucosa of the upper alimentary and respiratory tracts in rats. | 2004-10 |
|
| Liquid phase overtone spectral investigations of 2,6-dimethylaniline and 2,4-dimethylaniline-evidence for steric nature of the ortho effect and the consequent base weakening. | 2004-08 |
|
| Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis. | 2004-04-01 |
|
| Update on olfactory mucosal metabolic enzymes: age-related changes and N-acetyltransferase activities. | 2004 |
|
| Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. | 2003-10 |
|
| An update of the National Toxicology Program database on nasal carcinogens. | 1997-10-31 |
|
| Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. | 1993-07 |
|
| Hepatic effects of xylidine isomers in rats. | 1979-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:41:01 GMT 2025
by
admin
on
Mon Mar 31 18:41:01 GMT 2025
|
| Record UNII |
4FT62OX08D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
90502
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2,6-XYLIDINE
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
DTXSID8026307
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
4FT62OX08D
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
87-62-7
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
28738
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
C007766
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
m11552
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
7098
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
6896
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
201-758-7
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY | |||
|
2094
Created by
admin on Mon Mar 31 18:41:01 GMT 2025 , Edited by admin on Mon Mar 31 18:41:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
IN VITRO
|
||
|
PARENT -> METABOLITE INACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|